Exclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients ...
Merit’s ViaVerte nerve ablation system for chronic lower-back pain expands Medtronic’s lineup of chronic pain treatments.
After its planned $230 million acquisition of Korean stent maker M.I.Tech sputtered out earlier this year, Boston Scientific is making up for it with an even bigger buy. The medtech giant now plans to ...